Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
| Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
|---|---|---|---|---|---|---|---|
| JEFFERIES LLC | 2347 | Avenue Strategic Partners, L.P. | 1417189 | 03/14/2011 | D/A | Indefinite | $180,300,000 |
| JEFFERIES LLC | 2347 | Ibex Israel Fund LLLP | 1639750 | 09/25/2020 | D/A | Indefinite | $180,206,597 |
| JEFFERIES LLC | 2347 | STRATEGIC VALUE SPECIAL SITUATIONS FUND III, L.P. | 1593943 | 09/12/2014 | D/A | Indefinite | $178,609,000 |
| JEFFERIES LLC | 2347 | Opko Health, Inc. | 944809 | 02/15/2013 | D | $175,000,000 | $175,000,000 |
| JEFFERIES LLC | 2347 | Avenue Strategic Partners, L.P. | 1417189 | 03/16/2010 | D/A | Indefinite | $173,000,000 |
| JEFFERIES LLC | 2347 | Alkeon Growth Offshore Fund II, Ltd. | 1503462 | 10/22/2021 | D/A | Indefinite | $172,094,561 |
| JEFFERIES LLC | 2347 | Oak Hill Capital Partners IV (Onshore Tax Exempt), L.P. | 1649172 | 06/08/2017 | D/A | $2,500,000,000 | $170,476,537 |
| JEFFERIES LLC | 2347 | BHR Offshore Fund, Ltd. | 1512742 | 03/11/2014 | D/A | Indefinite | $166,526,013 |
| JEFFERIES LLC | 2347 | Karyopharm Therapeutics Inc. | 1503802 | 12/08/2022 | D | $165,000,003 | $165,000,003 |
| JEFFERIES LLC | 2347 | Gargoyle Hedged Value QP Fund L P | 1308700 | 04/11/2011 | D/A | Indefinite | $161,521,042 |